Navigation Links
Curis Announces Hedgehog and Wnt Antagonist Data Presentation at,AACR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 17, 2007 - Curis, Inc. (NASDAQ:CRIS), a drug development company focused on novel targeted medicines primarily for cancer treatment, today announced that its data was included in two presentations at the 98th Annual Meeting of the American Association for Cancer Research (AACR).

At AACR, Curis also disclosed that its April 2005 discovery collaboration agreement with Genentech focused on developing drug candidates that target the Wnt signaling pathway, particularly for potential cancer indications. Abnormal activation of Wnt signaling is present in various cancers, including colon, breast and ovarian cancers. Developing drug candidates that are designed to inhibit, or antagonize, Wnt signaling could hopefully provide a potential option in certain cancers.

On April 14, data was presented during an Educational Session titled "Targeting the Wnt Pathway in Cancer," which included a discussion of the Curis-Genentech joint effort in the identification of small molecule inhibitors of the Wnt pathway, under the April 2005 discovery collaboration agreement. The parties' research efforts have yielded a class of Wnt antagonists that, in preclinical studies, inhibit the Wnt pathway by acting upstream of beta-catenin, which is believed to be an important molecular target in the Wnt pathway. Inhibiting such an upstream molecular target may represent an attractive approach for potential inhibition of the Wnt pathway in cancer cells with abnormally active Wnt signaling.

In addition to the Educational Session, a poster was also presented at the conference describing the use of Hedgehog antagonists in a preclinical pancreatic tumor model. In these studies, Genentech and Curis scientists used a potent small molecule antagonist of the Hedgehog pathway on mice implanted with primary human pancreatic cancer xenografts. The scientists found that antagonizing the Hedgehog pathway res
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:12/15/2014)... 2014 Registreer nu via  http://bit.ly/ag8Sypm14de ... 20. Februar sind alle akkreditierten pharmazeutischen Patientenversorgungsakten-Firmen ... PARTNER PROGRAMM ™ 2015 in ... Diese Tagung soll dazu beitragen, der Aegate ... neue profitablen Unternehmensdienstleistungen, die für Apotheken und ...
(Date:12/15/2014)... 15, 2014 BerGenBio AS, a ... drug resistant cancers, today announces that it has raised ... from new and existing investors. BerGenBio will ... development of its pipeline of innovative cancer therapeutics, in ... drug candidate, BGB324, a first-in-class selective Axl kinase inhibitor, ...
(Date:12/15/2014)... -- Investor-Edge has initiated coverage on the following ... and Company (NYSE: LLY ), Nektar Therapeutics (NASDAQ: ... and Novartis AG (NYSE: NVS ). Free research ... . On Friday, December 12, 2014, the NASDAQ ... Average lost 1.79%, to finish the day at 17,280.83, and ...
Breaking Medicine Technology:Symposium über Aegates Ecosystem-Partner-Programm für sichere Medikamente vom 19. - 20. Februar 2015 in Amsterdam 2BerGenBio Completes NOK90 Million Fundraising 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 2Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 3Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 4Analysts View on Pharma Equities - Zogenix, Eli Lilly, Nektar Therapeutics, Sanofi, and Novartis 5
... -- Neuropsychiatric Data from Pivotal Trial Presented at Annual ... American Association for Geriatric Psychiatry ... ,Medivation, Inc. (Nasdaq: MDVN ) today announced that ... that behavioral symptoms were,stabilized in patients with mild-to-moderate Alzheimer,s ...
... Laser Technology gives patients new lease on life, ... facial plastic,surgeon is giving hope to patients suffering from ... FX by Lumenis is a fractional laser procedure performed ... procedure, a,high- energy beam of laser light is used ...
Cached Medicine Technology:Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 2Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 3Medivation's Dimebon(TM) Stabilizes Behavioral Symptoms in Alzheimer's Disease Patients, Resulting in Reduced Caregiver Distress 4Miami Plastic Surgeon Offers Hope to Acne Scarred Patients 2
(Date:12/17/2014)... Dr. Myo Nwe is the co-author of a ... Future” and co-founder of the Ace Medical Weight Loss Center ... a broad look at the industry of weight loss, and ... On film and in television shows, however, she says the ... aspects and played for basic laughs, which she believes impacts ...
(Date:12/17/2014)... December 17, 2014 A group of 127 ... Longevity, today, in reaction to a recent statement by the ... brain training and derogated the efficacy of all brain exercises. ... with the parts of the center’s statement critical of brain ... center had also overstated its case, in a document it ...
(Date:12/17/2014)... Project Veritas is releasing a video interview of ... and Obamacare architect Jonathan Gruber to public attention. Award-winning ... which is being distributed on YouTube. , During the ... the Affordable Care Act in order to hide a ... per year tax grab. , “President Obama promised us ...
(Date:12/17/2014)... 16, 2014 (HealthDay News) -- Poor students get more fruits ... new study finds. But, the opposite is true for ... fruits and vegetables at school may give a healthy boost ... no matter what the family income level, students all ate ... study found. The study was published recently in the ...
(Date:12/17/2014)... By Kathleen Doheny ... -- Chronic sleep loss is rampant in America, and work ... "Work is the No. 1 sleep killer," said Dr. Mathias ... at the University of Pennsylvania Perelman School of Medicine. ... and older, found that work is the main activity exchanged ...
Breaking Medicine News(10 mins):Health News:Obesity Should Not Be a Hollywood Punchline, Weight Loss Doc Says 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 2Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 3Health News:Scientists to Stanford: Research Shows Brain Exercises Can Work 4Health News:Project Veritas: James O’Keefe Interviews the Man Who Discovered Jonathan Gruber Videos 2Health News:Poor Students Eat Healthier Foods at School, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3
... shows often spray crime scenes with a compound called luminol ... of Medicine in St. Louis have applied the same compound ... attacks the body,s own tissues. , The authors report in ... sites of active immune inflammation in living mice, and that ...
... by researchers at the University of California, Santa Cruz, ... could be used for chemical and biological sensors and ... nanospheres developed in the laboratory of Jin Zhang, a ... unique set of properties, including strong, narrow, and tunable ...
... patients are nervous, doctors say it isn,t as scary as ... part of Colorectal Cancer Awareness Month, Americans are being urged ... highly preventable type of cancer. , But many people are ... which is recommended if you,re age 50 or older or ...
... D.O., has partnered to read digital retinal images for Retasure™ by ... assessment for diabetics. Dr. Shettle is a board certified Fellow of ... the American Academy of Ophthalmology. He is a practicing General Ophthalmologist ... ...
... innovative research in this critically under-served population. , ... ... Migraine Research Foundation (MRF) announced a new initiative to promote ... Children. The new program is a multi-faceted funding plan intended ...
... Digital Capability to the Next Level , ... Mt. Kisco, NY (PRWEB) ... a full-service health, beauty and lifestyle PR firm in Mt. Kisco, N.Y., ... as Chatter RL&A,s director of social media. Chatter RL&A is ...
Cached Medicine News:Health News:TV crime drama compound highlights immune cells' misdeeds 2Health News:TV crime drama compound highlights immune cells' misdeeds 3Health News:Hollow gold nanospheres show promise for biomedical and other applications 2Health News:Hollow gold nanospheres show promise for biomedical and other applications 3Health News:What to Expect From a Colonoscopy 2Health News:President of the Florida Osteopathic Medical Association Joins With Retasure™ to Prevent Vision Loss 2Health News:New Initiative to Support Pediatric Migraine Research Announced 2Health News:Robin Leedy & Associates Hires Director of Social Media 2Health News:Robin Leedy & Associates Hires Director of Social Media 3
Available in Purple, orange, dark blue, yellow, gray, royal blue, green and light blue colors....
Icefire has ice crystals on the top of a cool blue iris....
This pattern transform your pupils into narrow slits surrounded by eye stopping yellow. Works well with kitty-cat costumes....
Silicone tip cannula angled at 7 mm, sterile, disposable (bx/10)....
Medicine Products: